2019 Post Graduate Convention Registration

Register Here!

2019 PGC Brochure

Download Registration Form

2019 Exhibitor

Exhibitors Register Here!

Download Exhibitor Form


oao_logo_color  OMA-LogoName_large

Joint Providership by the Oregon Medical Association


World Forestry Center
4033 SW Canyon Road
Portland, Oregon 97221

March 8, 2019
8:00am to 5:00pm (breakfast at 7:30am)
President’s Reception in the Discovery Museum at 5:00pm
March 9, 2019
8:00am to 3:30pm (breakfast at 7:30am)

Target Audience

This activity has been planned for ophthalmology physicians (practicing and retired), and residents in the Pacific Northwest.

Accreditation | CME

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint Providership of the Oregon Medical Association (OMA) and the Oregon Academy of Ophthalmology (OAO). The OMA is accredited by the ACCME to provide continuing medical education for physicians.

The Oregon Medical Association designated this live activity for a maximum of 13 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

2019 Faculty

Ronald Gross, MD

David M. Brown, MD

Clinical Professor of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Research Director, Retina Consultants of Houston, Houston, Texas

Thomas Oetting, MD

Thomas A. Oetting, MS, MD

CATARACT: Rudy & Margaret Perez Prof of Ophthalmology, Director of Ophthalmology, Residency Program, Chief of Ophthalmology & Deputy Director for Surgery, University of Iowa, Chief of Eye Service & Deputy Director of Surgery Service, VA Medical Center, Iowa City, Iowa

Thomas Oetting, MD

Valerie Biousse, MD

Cyrus H. Stoner Professor of Ophthalmology, Professor of Ophthalmology & Neurology, Emory University School of Medicine, Atlanta, Georgia

Sunita Radhakrishnan, MD

Sunita Radhakrishnan, MD

Associate, Glaucoma Center of San Francisco, Research Director, Glaucoma Research & Education Group, San Francisco, California

Justin Leitenberger, MD

Justin Leitenberger, MD

Assistant Professor, Department of Dermatology, Director, High-Risk Non-Melanoma Skin Cancer Clinic, Micrographic Surgery and Dermatologic Oncology, Oregon Health & Science University, Portland, Oregon

Draft Agenda

Friday, March 8, 2019

7:30 – 8:00 AM Breakfast Buffet & Exhibitor Visits
8:00 – 8:05 AM President’s Welcome Jennifer Lyons, MD
8:05 – 8:45 AM Assessment of the AC Angle: Gonioscopy & Imaging Sunita Radhakrishnan, MD
8:45 – 9:25 AM 25 Years Teaching Tips Thomas Oetting, MS, MD
9:25 – 10:05 AM OCT: Earth & Space David Brown, MD
10:05 – 10:25 AM Break & Exhibitor Visits
10:25 – 11:05 AM Acute Retinal Arterial Ischemia: An Emergency Often Ignored Valerie Biousse, MD
11:05 – 11:45 PM Management of Primary Angle Closure Sunita Radhakrishnan, MD
11:45 – Noon Annual Business Meeting
Noon – 1:00 PM Lunch
1:00 – 1:40 PM Learning From Social Media Thomas Oetting, MS, MD
1:40 – 2:40 PM The Next Frontier: Gene Therapy for Retinal Disease David Brown, MD
2:40 – 3:00 PM Break & Exhibitor Visits
3:00 – 3:40 PM Ophthalmology in the 21st Century: The FOTO-ED Story Valerie Biousse, MD
3:40 – 4:20 PM Current Status of Medical Therapy for Glaucoma Sunita Radhakrishnan, MD
4:20 – 5:00 PM Nucleofractis From Soft to Hard Lenses Thomas Oetting, MS, MD
5:00 PM President’s Reception in the Discovery Museum

Saturday, March 9, 2019

7:30 – 8:00 AM Breakfast Buffet & Exhibitor Visits
8:00 – 8:40 AM Update on Idiopathic Intracranial Hypertension Valerie Biousse, MD
8:40 – 9:40 AM WORKSHOP: Illustrative Cases for Diagnostic, Medical Therapy and Surgical Treatment Sunita Radhakrishnan, MD
9:40 – 10:00 AM Break & Exhibitor Visits
10:00 – 11:00 AM WORKSHOP: What Went Wrong? A Series of Interactive Cases in Which an Error was Made  Valerie Biousse, MD
11:00 – 12:00 PM WORKSHOP: Cool Ophthalmology Cases Thomas Oetting, MS, MD
12:00 – 1:00 PM Lunch
1:00 – 1:40 PM Diabetic Retinopathy 2019 David Brown, MD
1:40 – 2:40 PM WORKSHOP: Advances in Imaging: OCTA & Wide Field David Brown, MD
2:40 – 3:20 PM The Eyes of March: Ohs Micrographic Surgery & Management of Periocular Tumors Justin Leitenberger, MD
3:20 PM  Adjourn


  1. Learn the imaging characteristics, indications, and use of anti-VEGF medications.
  2. Understand how sequential photography and other testing methods can better delineate the growth of skin cancers around the eye.
  3. Learn to use gonioscopy to evaluate the different mechanisms and stages of angle closure.
  4. Learn how to appropriately manage ischemic optic neuropathy.
  5. Learn, through discussion and videos, how remove cataract lenses with a hard consistency with a new wire loop device.
  6. Physicians will learn how social media can improve their competence.
  7. Tips on how to succeed by learning existing skills in residency or new skills during practice.
  8. Learn the correct treatment options for idiopathic intracranial hypertension.


The Eyes of March: Management of Periocular Tumors | Justin Leitenberger, MD

  1. Identify clinical features of common skin cancer presentations.
  2. Discuss staging and work-up for skin cancers with high risk features.
  3. Review Mohs surgical technique for treatment of skin cancer in the periocular region.

Five Teaching Tips | Thomas Oetting, MD

  1. Define key aspects of structured for cataract surgery.
  2. List ways to decrease the risk of learning surgeons.
  3. List advantages of an integrated internship.

Nucleofractis from Soft to Hard Lenses | Thomas Oetting, MD

  1. Describe the advantages of using snare devices for nucleofractis in hard lenses.
  2. Describe the use of soft chop and soft prolapse for soft lenses.
  3. List the complications from chopping.

Learning from Social Media | Thomas Oetting, MD

  1. List popular social media outlets for medicine.
  2. Describe ways social media allows learning in medicine.
  3. List physician uses of social media.

Workshop Cool Cases | Thomas Oetting, MD

  1. Describe the advantages of posterior capsule capture of the optic.
  2. Describe the advantages of removing the second instrument.
  3. List the steps to reposition the iris after prolapse.
  4. List the steps for best placement of iris hooks.

Assessment of the Anterior Chamber Angle and Diagnosis of Angle Closure | Sunita Radhakrishnan, MD

  1. Recognize gonioscopic features of the angle in various conditions.
  2. Explain differences between the different methods of evaluating the AC angle.
  3. Explain how imaging can be used to assess various mechanisms of angle closure.

Primary Angle Closure Closure | Sunita Radhakrishnan, MD

  1. Distinguish the different stages of primary angle closure.
  2. Describe the effect of iridotomy in each stage of primary angle closure.
  3. Explain the role of lens removal in the treatment of primary angle closure.

Current Status of Medical Therapy for Glaucoma Closure | Sunita Radhakrishnan, MD

  1. List the classes of IOP lowering medications.
  2. Identify problems with medical therapy.
  3. Understand the factors that influence choice of first-line and adjunct medical therapy.

Workshop: Case PresentationsClosure | Sunita Radhakrishnan, MD

  1. This presentation will include description of cases that illustrate various aspects of glaucoma management.

Acute Retinal Arterial Ischemia: An Emergency Often Ignored | Valerie Biousse, MD

  1. Review guidelines for the management of acute stroke.
  2. Discuss the differential diagnosis of transient visual loss.
  3. Apply stroke guidelines to patients with acute retinal ischemia.

Ophthalmoscopy in the 21stCentury: The FOTO-ED Study | Valerie Biousse, MD

  1. Discuss barriers to the use of ophthalmoscopy by non-eye care providers.
  2. Review the use of nonmydriatic fundus photography in the emergency department and in neurology settings.
  3. Review the FOTO-ED study and its applications in clinical practice.

Update on Idiopathic Intracranial Hypertension | Valerie Biousse, MD

  1. Review the latest diagnostic criteria for idiopathic intracranial hypertension.
  2. Discuss evidence-based treatments of idiopathic intracranial hypertension.
  3. Review current and upcoming clinical trials in idiopathic intracranial hypertension.

What Went Wrong? A Series of Interactive Cases in Which an Error was Made | Valerie Biousse, MD

  1. Understand common causes of diagnostic and management errors in neuro-ophthalmology.
  2. Develop strategies to prevent diagnostic errors.
  3. Review best practices in a few neuro-ophthalmologic disorders.

OCT: Earth & Space | David M. Brown, MD

  1. Assess the detection and diagnosis of retinal pathology using OCT.
  2. Review pathophysiology of diabetic retinopathy and age-related macular degeneration as shown on OCT.
  3. Understand the OCT changes involving long-term space travel.

The Next Frontier: Gene Therapy for Retinal Disease | David M. Brown, MD

  1. Discern the mechanisms of gene therapy and retinal disease.
  2. Explore gene therapy of inherited retinal diseases.
  3. Understand gene therapy as a drug delivery system.

Diabetic Retinopathy 2019

  1. Review the pathophysiology of diabetic retinopathy.
  2. Comprehend the diagnosis and management of diabetic retinopathy.
  3. Ascertain the role of anti-VEGF agents and laser for diabetic macular edema, PDR, and NPDR.

Advances in Imaging: OCTA & Wide Field Imaging | David M. Brown, MD

  1. Identify cases in which OCTA and WF imaging are necessary or useful.
  2. Review case examples of retinal disease findings in OCT and WF imaging.
  3. Examine the future of OCTA and WF imaging.

Faculty Disclosure Policy

It is the policy of the Oregon Medical Association (OMA) to ensure balance, independence, objectivity, and scientific rigor in its CME activities. To comply with the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education (ACCME), the OMA requires members of the planning committee, applicable staff and faculty to disclose the existence of those commercial interests which produce, market, re-sell, or distribute health care goods or services consumed by, or used on patients with which he/she or their spouse/partner either: a) have a relevant financial relationship now, or b) have had a relevant financial relationship during the past 12 months. Non-profit companies, non-health care related companies and government organizations do not need to be included.

Faculty members have declared that they will uphold the OMA’s standards regarding CME activities and that any clinical recommendations are based on the best available evidence or are consistent with generally accepted medical practice.  Please indicate in the comments section of the evaluation form whether you detect any instances of bias toward products manufactured by commercial interests. Please click here to review our 2019 faculty, planning committee and staff disclosures.